Print

HVTN 063

A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Gag DNA Vaccine Alone or With IL-15 DNA, Boosted With HIV-1 Gag DNA + IL-15 DNA or HIV-1 Gag DNA + IL-12 DNA, in Healthy, HIV-1 Uninfected Adult Participants

Trial Details:

I Completed
Wyeth, Profectus Biosciences, National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) September 08, 2005
HIV-1 gag DNA Gag B
HIV-1 gag DNA DNA
IL-15 DNA adjuvant
USA 156
NCT00115960
http://www.clinicaltrials.gov/ct/show/NCT00115960?order=1